Silymarin for prevention of anti-Tuberculosis drug-induced liver injury: Aa metaanalysis

被引：0
|
作者：
Floro, Geraldine Claire O. [1 ]
Fausto, Adrian Manuel [1 ]
Velasco, Mariel Dianne [1 ]
Camenforte, Jenis Emmanuel [1 ]
De Lusong, Mark Anthony [1 ]
机构：
[1] Univ Philippines, Philippine Gen Hosp, Dept Med, Gastroenterol Sect, Quezon City, Philippines
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-0967
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [1] Anti-tuberculosis drug-induced liver injury
    Lim, Wei Shen
    Avery, Anthony
    Kon, Onn Min
    Dedicoat, Martin
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 383
  • [2] Genetic Variations Associated with Anti-Tuberculosis Drug-Induced Liver Injury
    Bao Y.
    Ma X.
    Rasmussen T.P.
    Zhong X.-B.
    [J]. Current Pharmacology Reports, 2018, 4 (3) : 171 - 181
  • [3] The Effectiveness of Silymarin in the Prevention of Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized Controlled Clinical Trial
    Talebi, Ali
    Soltani, Rasool
    Khorvash, Farzin
    Jouabadi, Soroush Mohammadi
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2023, 14 (01)
  • [4] Silymarin in Preventing Anti-Tuberculosis and Antipsychotic Drug-Induced Liver Injury at Different Doses and Treatment Times: A Systematic Review
    Sheng, Ying Kun
    Zhang, Lu
    Hong, Yin
    [J]. IRANIAN RED CRESCENT MEDICAL JOURNAL, 2019, 21 (10)
  • [5] Mitochondrial Dna Variants In Drug-Induced Liver Injury By Anti-Tuberculosis Agents
    Chang, H. -C.
    Lee, L. -N.
    Jan, I. -S.
    Lo, S. -C.
    Cheng, W. -C.
    Lee, Y. -F.
    Wang, J. -Y.
    Hsu, C. -L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] Transforming growth factor-beta 1 polymorphisms and anti-tuberculosis drug-induced liver injury. Polymorphisms in TGFβ1 and its relationship with anti-tuberculosis drug-induced liver injury
    Wu, Shouquan
    Wang, Yu
    Zhang, Miaomiao
    Wang, Minggui
    He, Jian-Qing
    [J]. THERAPIE, 2019, 74 (03): : 399 - 406
  • [7] Plasma metabolomic and lipidomic alterations associated with anti-tuberculosis drug-induced liver injury
    Wang, Ming-Gui
    Wu, Shou-Quan
    Zhang, Meng-Meng
    He, Jian-Qing
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Efficacy and safety of bicyclol for treating patients with anti-tuberculosis drug-induced liver injury
    Du, Y.
    Gu, J.
    Yang, Y.
    Chen, Y.
    Wang, Y.
    Mei, Z.
    Li, Y.
    Li, L.
    Xue, D.
    Wang, X.
    Li, D.
    Hu, P.
    Nie, W.
    Chu, N.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2024, 28 (01) : 6 - 12
  • [9] Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
    Wanvisa Udomsinprasert
    Noppadol Chanhom
    Supharat Suvichapanich
    Sukanya Wattanapokayakit
    Surakameth Mahasirimongkol
    Wasun Chantratita
    Jiraphun Jittikoon
    [J]. Scientific Reports, 10
  • [10] Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury
    Udomsinprasert, Wanvisa
    Chanhom, Noppadol
    Suvichapanich, Supharat
    Wattanapokayakit, Sukanya
    Mahasirimongkol, Surakameth
    Chantratita, Wasun
    Jittikoon, Jiraphun
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
12345